ReviewCurrent diabetes reports2020

Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony.

Stanley M H Yeung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.